Global HIV-AIDS Testing Market 2014-2018

Global HIV-AIDS Testing Market 2014-2018

Category : Medical Devices
Published On : April  2014
Pages : 99



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

About HIV-AIDS Testing
AIDS is a condition caused due to the gradual weakening of the human body's immune system. This weakening is caused by a virus called HIV, which attacks the body's white blood cells, specifically a subset called CD4 or helper T cells.  AIDS/HIV testing devices are medical devices that are used to determine the presence of HIV in human blood. A number of testing devices are available including the HIV antibody test, the Antigen (P24) test, and the PCR test. 
TechNavio's analysts forecast the Global HIV-AIDS Testing market will grow at a CAGR of 5.43 percent over the period 2013-2018.
Covered in this Report
The Global HIV-AIDS Testing market can be divided into three segments: HIV-AIDS Screening Assays, HIV-AIDS Confirmatory Assays, and HIV-AIDS Monitoring Assays. 
TechNavio's report, the Global HIV-AIDS Testing Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global HIV-AIDS Testing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas 
• EMEA        
• APAC
Key Vendors
• Abbott Laboratories
• Bio-Rad Laboratories Inc.
• Hologic Inc.
• Ortho-Clinical Diagnostics Inc.
• Roche Diagnostics
• Siemens Healthcare Diagnostics Inc.
Other Prominent Vendors
 
• bioMerieux SA
• Calypte Biomedical Corp.
• Fujirebio Diagnostics Inc.
• Medical Services International Inc.
• MedMira Laboratories Inc.
• OraSure Technologies Inc.
• Quest Diagnostics Inc.
• Trinity Biotech plc
Market Driver
• Increase in Number of People Prone to HIV/AIDS.
• For a full, detailed list, view our report.
Market Challenge
• Intense Competition among Vendors.
• For a full, detailed list, view our report.
Market Trend
• Adoption of AIDS/HIV Workplace Policies by Companies.
• For a full, detailed list, view our report.
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report


03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. HIV and AIDS Overview

05.1.1 Types of HIV

06. Introduction

07. Market Landscape


07.1 Market Overview

07.2 Market Size and Forecast

07.3 Five Forces Analysis

08. Market Segmentation by Category

08.1 Global HIV-AIDS Testing Market by Category

09. Types of HIV Tests

09.1.1 Antibody Tests

09.1.2 Antigen Tests

09.1.3 PCR Tests

10. Geographical Segmentation

10.1 Global HIV-AIDS Testing Market by Geographical Segmentation

11. Top 20 Countries with HIV Infected Population

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape


19.1 Competitive Scenario

19.1.1 Key News

19.1.2 Mergers and Acquisitions

19.2 Market Share Analysis 2013

19.3 Other Prominent Vendors

20. Key Vendor Analysis

20.1 Abbott Laboratories

20.1.1 Key Facts

20.1.2 Business Description

20.1.3 Business Segmentation

20.1.4 Business Strategy

20.1.5 Revenue Segmentation

20.1.6 Revenue Comparison  2012 and 2011

20.1.7 Geographical Segmentation

20.1.8 Key Information

20.1.9 SWOT Analysis

20.1.10 Strengths

20.1.11 Weakness

20.1.12 Opportunities

20.1.13 Threats

20.2 Bio-Rad Laboratories Inc.

20.2.1 Key Facts

20.2.2 Business Description

20.2.3 Business Segmentation

20.2.4 Business Strategy

20.2.5 Revenue Segmentation of Bio-Rad Laboratories Inc.

20.2.6 Revenue Comparison FY2012 and FY2011

20.2.7 Bio-Rad Laboratories Inc. by Geographical Segmentation

20.2.8 Key Information

20.2.9 SWOT Analysis

20.2.10 Strengths

20.2.11 Weakness

20.2.12 Opportunities

20.2.13 Threats

20.3 Hologic Inc.

20.3.1 Key Facts

20.3.2 Business Description

20.3.3 Business Segmentation

20.3.4 Business Strategy

20.3.5 Revenue Segmentation

20.3.6 Revenue Comparison FY2012 and FY2013

20.3.7 Geographical Segmentation

20.3.8 Key Information

20.3.9 SWOT Analysis

20.3.10 Strengths

20.3.11 Weaknesses

20.3.12 Opportunities

20.3.13 Threats

20.4 Ortho-Clinical Diagnostics Inc.

20.4.1 Key Facts

20.4.2 Business Overview

20.4.3 Key Information

20.4.4 SWOT Analysis

20.4.5 Strengths

20.4.6 Weakness

20.4.7 Opportunities

20.4.8 Threats

20.5 Roche Diagnostics

20.5.1 Key Facts

20.5.2 Business Description

20.5.3 Business Segmentation

20.5.4 Revenue Segmentation

20.5.5 Geographical Segmentation

20.5.6 Business Strategy

20.5.7 Key Information

20.5.8 SWOT Analysis

20.5.9 Strengths

20.5.10 Weaknesses

20.5.11 Opportunities

20.5.12 Threats

20.6 Siemens Healthcare Diagnostics Inc.

20.6.1 Key Facts

20.6.2 Business Overview

20.6.3 Key Information

20.6.4 Business Strategy

20.6.5 SWOT Analysis

20.6.6 Strengths

20.6.7 Weaknesses

20.6.8 Opportunities

20.6.9 Threats

21. Other Reports in this Series



Exhibit 1: Market Research Methodology

Exhibit 2: Global HIV-AIDS Testing Market Overview

Exhibit 3: Global HIV-AIDS Testing market 2013-2018 (US$ billion)

Exhibit 4: Global HIV-AIDS Testing Market Segmentation by Category

Exhibit 5: Global HIV-AIDS Testing Market Segmentation by Category 2013

Exhibit 6: Types of HIV Tests

Exhibit 7: Global HIV-AIDS Testing Market by Geographical Segmentation 2013

Exhibit 8: Top 20 HIV Infected Countries with HIV Infected Population 2012

Exhibit 9: Business Segmentation of Abbott Laboratories

Exhibit 10: Revenue Segmentation of Abbott Laboratories 2012

Exhibit 11: Revenue Comparison 2012 and 2011 (US$ million)

Exhibit 12: Abbott Laboratories by Geographical Segmentation 2012

Exhibit 13: Business Segmentation of Bio-Rad Laboratories Inc.

Exhibit 14: Revenue Segmentation of Bio-Rad Laboratories Inc. FY2012

Exhibit 15: Revenue Comparison 2012 and 2011(US$ million)

Exhibit 16: Bio-Rad Laboratories Inc. by Geographical Segmentation 2012

Exhibit 17: Business Segmentation of Hologic Inc.

Exhibit 18: Revenue Segmentation of Hologic Inc. 2013

Exhibit 19: Revenue Comparison FY2012 and FY2013 (US$ million)

Exhibit 20: Hologic Inc. by Geographical Segmentation 2013

Exhibit 21: Business Segmentation of Roche Diagnostics

Exhibit 22: Revenue Segmentation of Roche Diagnostics FY2013

Exhibit 23: Roche Diagnostics by Geographical Segmentation FY2013



 


Enquiry Before Buy
image
Can´t read the image ? refresh here.